BR112019005722A2 - emplastro para aplicação na pele de um indivíduo e método para o tratamento de uma desordem de pele - Google Patents

emplastro para aplicação na pele de um indivíduo e método para o tratamento de uma desordem de pele

Info

Publication number
BR112019005722A2
BR112019005722A2 BR112019005722A BR112019005722A BR112019005722A2 BR 112019005722 A2 BR112019005722 A2 BR 112019005722A2 BR 112019005722 A BR112019005722 A BR 112019005722A BR 112019005722 A BR112019005722 A BR 112019005722A BR 112019005722 A2 BR112019005722 A2 BR 112019005722A2
Authority
BR
Brazil
Prior art keywords
skin
patch
treating
individual
application
Prior art date
Application number
BR112019005722A
Other languages
English (en)
Other versions
BR112019005722A8 (pt
Inventor
Heard Charles
Houston David
Harding Keith
Original Assignee
Neem Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neem Biotech Ltd filed Critical Neem Biotech Ltd
Publication of BR112019005722A2 publication Critical patent/BR112019005722A2/pt
Publication of BR112019005722A8 publication Critical patent/BR112019005722A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

a invenção refere-se a emplastro de tratamento médico, de preferência para a aplicação por via tópica, que permite que a liberação orientada, sustentada e controlada de kmno4 de potássio; e um método para tratar um distúrbio da pele compreendendo a aplicação do referido emplastro.
BR112019005722A 2016-09-23 2017-09-21 Emplastro para aplicação na pele de um indivíduo e método para o tratamento de uma desordem de pele BR112019005722A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1616223.2A GB201616223D0 (en) 2016-09-23 2016-09-23 Topical treatment patch
PCT/GB2017/052816 WO2018055376A1 (en) 2016-09-23 2017-09-21 Patch comprising potassium permanganate for the treatment of skin disorder

Publications (2)

Publication Number Publication Date
BR112019005722A2 true BR112019005722A2 (pt) 2019-07-09
BR112019005722A8 BR112019005722A8 (pt) 2023-04-11

Family

ID=57539902

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019005722A BR112019005722A8 (pt) 2016-09-23 2017-09-21 Emplastro para aplicação na pele de um indivíduo e método para o tratamento de uma desordem de pele

Country Status (19)

Country Link
US (1) US11129800B2 (pt)
EP (1) EP3515416B1 (pt)
JP (1) JP7066692B2 (pt)
KR (1) KR102552765B1 (pt)
CN (1) CN109982688B (pt)
AU (1) AU2017332832B2 (pt)
BR (1) BR112019005722A8 (pt)
CA (1) CA3037807A1 (pt)
DK (1) DK3515416T3 (pt)
ES (1) ES2954142T3 (pt)
GB (1) GB201616223D0 (pt)
HU (1) HUE063088T2 (pt)
IL (1) IL265581B2 (pt)
MX (1) MX2019003347A (pt)
PL (1) PL3515416T3 (pt)
PT (1) PT3515416T (pt)
RU (1) RU2770064C2 (pt)
WO (1) WO2018055376A1 (pt)
ZA (1) ZA201902228B (pt)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3839246A (en) * 1973-08-09 1974-10-01 Gen Electric Two-part room temperature vulcanizable systems
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
JPS59104314A (ja) * 1982-11-09 1984-06-16 Hisamitsu Pharmaceut Co Inc 新規貼付薬
JP2659961B2 (ja) * 1986-08-18 1997-09-30 中外製薬株式会社 経皮吸収貼付剤
US5792090A (en) 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
JPH10158155A (ja) * 1996-11-29 1998-06-16 Tac Medical Kk 貼付剤
ATE438418T1 (de) * 2001-05-01 2009-08-15 Av Topchiev Inst Petrochemical Hydrogel-zusammensetzungen
US20030180281A1 (en) * 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
JP2004321785A (ja) * 2003-04-07 2004-11-18 Ube Ind Ltd 医療用パッチ及びその製造方法
CN1929819B (zh) * 2004-01-30 2012-02-29 考里安国际公司 递送活性剂的快速溶解膜
RU2411045C2 (ru) * 2005-01-27 2011-02-10 Институт Нефтехимического Синтеза Имени А.В. Топчиева Ран Гидрофильные биологически совместимые адгезивные композиции и их применение
JP2006248996A (ja) * 2005-03-10 2006-09-21 Nitto Denko Corp 経皮吸収型貼付剤
DE102006025282A1 (de) * 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
WO2013162723A1 (en) * 2012-04-27 2013-10-31 Dow Corning Corporation Topical formulation compositions containing silicone based excipients to deliver actives to a substrate
CN103819799B (zh) * 2014-03-07 2016-02-24 福州大学 一种聚合物/高锰酸钾复合薄膜及其制备方法
AU2016222274B2 (en) * 2015-02-16 2020-11-26 Tekcyte Limited Methods and products for delivering cells
EP3446693B1 (en) * 2015-02-19 2020-11-11 Hiantis S.r.l. Pharmaceutical compositions and formulations comprising aluminium acetate for topical application with astringent and antimicrobial effect
US20160317699A1 (en) * 2015-04-28 2016-11-03 Frank DiCosmo Antimicrobial adhesive dressings

Also Published As

Publication number Publication date
ZA201902228B (en) 2022-12-21
BR112019005722A8 (pt) 2023-04-11
KR20190080869A (ko) 2019-07-08
CA3037807A1 (en) 2018-03-29
IL265581B2 (en) 2023-04-01
JP7066692B2 (ja) 2022-05-13
ES2954142T3 (es) 2023-11-20
CN109982688A (zh) 2019-07-05
IL265581B (en) 2022-12-01
AU2017332832A1 (en) 2019-04-18
HUE063088T2 (hu) 2023-12-28
PL3515416T3 (pl) 2024-01-15
MX2019003347A (es) 2019-10-07
KR102552765B1 (ko) 2023-07-10
EP3515416A1 (en) 2019-07-31
DK3515416T3 (da) 2023-09-04
EP3515416B1 (en) 2023-06-07
JP2019533648A (ja) 2019-11-21
AU2017332832B2 (en) 2023-04-27
WO2018055376A1 (en) 2018-03-29
RU2019112100A3 (pt) 2020-12-11
CN109982688B (zh) 2023-08-15
IL265581A (en) 2019-05-30
GB201616223D0 (en) 2016-11-09
RU2770064C2 (ru) 2022-04-14
US20190224133A1 (en) 2019-07-25
PT3515416T (pt) 2023-09-07
US11129800B2 (en) 2021-09-28
RU2019112100A (ru) 2020-10-23

Similar Documents

Publication Publication Date Title
CL2019000979A1 (es) Composiciones y anticuerpos anti-lag-3.
BR112017025166A2 (pt) métodos de condicionar pacientes para terapia de células t
BR112019005312A2 (pt) dispositivos e métodos para a recomposição cosmética da pele
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
CL2015000699A1 (es) Métodos para tratamiento de cáncer.
MX2015011296A (es) Dispositivo foto-terapeutico, metodo y uso.
BR112016029334A2 (pt) produto farmacêutico, uso de um anticorpo, kit, método para tratar um paciente com câncer e métodos e usos de novos produtos
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
CL2019002368A1 (es) Composiciones y métodos para el tratamiento de cáncer.
BR112017016759A2 (pt) recipiente de plástico pré-carregado, kit, uso do recipiente de plástico pré-carregado, método para o tratamento de uma doença ou condição, método para o tratamento cosmético da pele
BR112017014275A2 (pt) ?aparelho e método de tratamento de pele?
BR112017009584A2 (pt) tratamento de retinite pigmentosa com n-acetilcisteína amida
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
BR112019003731A2 (pt) aplicação de pridopidina para tratamento de distonias
BR112018011991A2 (pt) dispositivo para cuidados com o corpo para tratar uma pele, cabeça de tratamento e método para tratar uma parte de uma pele
BR112019005040A2 (pt) aplicação de pridopidina para tratamento de síndrome de rett
BR112018005267A2 (pt) processo para realizar fototerapia ou fotoestimulação de retina, e sistema para realizar fototerapia ou fotoestimulação de retina
CO2021014768A2 (es) Anticuerpos anti-sema3a y sus usos para tratar enfermedades oculares
BR112017027897A2 (pt) usos terapêuticos das formulações de berberina
BR112019008241A2 (pt) tratamento do prurigo nodular
CL2021001554A1 (es) Métodos para el tratamiento de discinesia en parálisis cerebral.
CL2013003066A1 (es) Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion
BR112019000706A8 (pt) Agente de estímulo do receptor 1b de 5-hidroxitriptamina para reparo de pele e/ou cabelo
BR112019005722A2 (pt) emplastro para aplicação na pele de um indivíduo e método para o tratamento de uma desordem de pele

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: ONYA THERAPEUTICS LIMITED (GB)